Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Exagen Inc. (Nasdaq: XGN) will participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16th, 2023. Exagen's President and CEO, John Aballi, and CFO, Kamal Adawi, will present at 9:30 AM ET. The webcast of the presentation can be accessed on Exagen's website.
11/02/2023 - 04:05 PM
SAN DIEGO, California, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, which takes place November 16th , 2023, at the Westin New York Grand Central Hotel in New York City. John Aballi, Exagen’s President and Chief Executive Officer and Kamal Adawi, Exagen’s Chief Financial Officer, will present at 9:30 AM ET. Interested parties may access the webcast of the presentation using a link on Exagen’s website at https://investors.exagen.com/events .
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.
For more information, please visit Exagen.com and follow @ExagenInc on Twitter.
Investor Relations Exagen Inc. Ryan Douglasrdouglas@exagen.com 760.560.1525
Company Exagen Inc. Kamal Adawi, Chief Financial Officerkadawi@exagen.com
What event is Exagen Inc. participating in?
Exagen Inc. is participating in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum.
When is the event taking place?
The event is taking place on November 16th, 2023.
Who will be presenting at the event?
Exagen's President and Chief Executive Officer, John Aballi, and Chief Financial Officer, Kamal Adawi, will be presenting at the event.
How can interested parties access the webcast of the presentation?
Interested parties can access the webcast of the presentation on Exagen's website at https://investors.exagen.com/events.
XGN Rankings
#4255 Ranked by Stock Gains
XGN Stock Data
Industry
Dental Laboratories
Sector
Manufacturing
Tags
Health Services, Medical/Nursing Services, Manufacturing, Dental Laboratories
Country
US
City
Vista
About XGN
exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.